Objective: A potential strategy to treat obesity e and the associated metabolic consequences e is to increase energy expenditure. This could be achieved by stimulating thermogenesis through activation of brown adipose tissue (BAT) and/or the induction of browning of white adipose tissue (WAT). Over the last years, it has become clear that several metalloproteinases play an important role in adipocyte biology. Here, we investigated the potential role of ADAMTS5. Methods: Mice deficient in ADAMTS5 (Adamts5 À/À ) and wild-type (Adamts5 þ/þ ) littermates were kept on a standard of Western-type diet for 15 weeks. Energy expenditure and heat production was followed by indirect calorimetry. To activate thermogenesis, mice were treated with the b3- Conclusions: These data indicate that ADAMTS5 plays a functional role in development of BAT and browning of WAT. Hence, selective targeting of ADAMTS5 could provide a novel therapeutic strategy for treatment/prevention of obesity and metabolic diseases.
INTRODUCTION
Adipose tissue (AT) is a very dynamic and complex organ because of the challenges throughout evolution to which species had to adapt, namely limited food supplies and cold temperatures [1] . White AT (WAT) is adapted to store energy in the form of triglycerides and is located at several depots throughout the body, mostly subcutaneously and intra-abdominally. In brown AT (BAT), adipocytes are characterized by the abundance of mitochondria that produce heat (i.e. non-shivering thermogenesis). The uncoupling protein UCP-1 is the hallmark of brown adipocytes; it regulates conversion of energy into heat by uncoupling ATP production from mitochondrial respiration [2] . Interestingly, adaptive UCP-1 positive adipocytes can arise in mature WAT. Development of these brown in white ('brite' or beige) cell clusters, in predominantly subcutaneous (SC) WAT, is enhanced during adaptation to cold or in response to treatment with selective b 3 -adrenergic receptor agonists. It was reported that increasing the mass of brown and beige adipocytes in human resulted in reduction of body weight and fat mass and improvement of glucose metabolism including insulin sensitivity [3] . Therefore, strategies to induce BAT formation and/or browning of WAT are considered a potential and promising therapeutic strategy to combat obesity and the associated metabolic diseases [4e 6]. However, at present, well-defined and effective metabolic or pharmacologic interventions are lacking. Proteolytic remodeling of the extracellular matrix (ECM) plays an important role in adipocyte behavior [7, 8] . The ECM consists of a heterogeneous mixture of collagens, glycoproteins and proteoglycans [9, 10] . These components are degraded by several classes of proteinases. The metzincin superfamily of zinc-dependent metalloproteinases comprises the MMP (matrix metalloproteinases), the ADAM (A Disintesgrin and Metalloproteinase) and the ADAMTS (ADAM with a Thrombospondin type-1 motif) subfamilies. For several of these proteinases a role in development of AT has been documented [7] , but little information is available on the ADAMTS group. We have previously 1 observed expression of ADAMTS1, 4, 5, and 8 in murine AT and marked upregulation of ADAMTS5 during development of obesity [9, 11] . Increased expression of ADAMTS5 was confirmed in rat AT during high fat diet (HFD) feeding [12] . In addition, Koza et al. showed a positive correlation between ADAMTS5 expression in AT and interindividual fat mass differences in genetically identical C57Bl/6J obese mice [13] . Furthermore, we have shown that ADAMTS5 promotes murine adipogenesis and WAT expansion [14] . In the present study, using a diet-induced obesity model in mice, we show that ADAMTS5 deficiency promotes BAT development as well as browning of WAT.
MATERIALS AND METHODS

Animals and experimental models ADAMTS5 wild-type (Adamts5
þ/þ ) and knockout (Adamts5 À/À ) mice (99.6% C57Bl/6J genetic background) were generated from heterogeneous breeding pairs and genotyped as described elsewhere [15] . [17] . Animals were fasted for a minimum of 6 h before undergoing PET. They were anesthetized using 2% isoflurane in 100% oxygen. After receiving the anesthesia, they were given a w11. Gels were transferred onto a 0.45 mm nitrocellulose membrane and blocked in 5% nonfat dry milk (Bio-Rad, Hercules, CA) in 10 mM Trise HCl buffer containing 150 mM NaCl and 0.05% Tween 20 at pH 7.6 (TBST) for 3 h. Subsequently, membranes were probed with the following primary antibodies: a-Tubulin (SigmaeAldrich), b-actin (Cell Signaling Technology; CST, Leiden, The Netherlands), pCREB (CST), PGC1a (Novus Biologicals), PRDM16 (R&D systems), tCREB (CST), UCP-1 (SigmaeAldrich) and Vinculin (SigmaeAldrich). Secondary antibodies were species-appropriate horseradish peroxidase conjugated (Dako, Glostrup, Denmark, 1:2000) in TBST containing 5% nonfat dry milk. Signals were detected with Enhanced Chemiluminescence (Thermo Fisher Scientific).
Biochemical analysis
The triglyceride content in BAT was quantified with the triglycerides FS* kit (Diasys, Holzheim, Germany) as described [21] . Commercially available ELISAs were used to monitor endoglin (R&D systems, Abingdon, UK) and FGF-21 (R&D systems). Figure 1E ,F), whereas for both genotypes triglyceride levels were increased on HFD as compared to SFD feeding. Thus, the genotype of their initial body weight, respectively ( Figure S1 ). Food and water intake, as well as VO 2 , VCO 2 , and RER, did not differ during the experimental period ( Figure S1 ). Locomotive activity was higher during periods of darkness, but was not different for both genotypes (Figure 2A ). Interestingly, energy expenditure ( Figure 2B ) and heat production ( Figure 2C ) were significantly enhanced for obese
Functional analysis of BAT by mPET scanning after 15 weeks of HFD demonstrated that ADAMTS5 deficient mice have normal, metabolically active BAT ( Figure S2 ). Ex vivo radiotracer gamma counting on interscapular BAT of Adamts5 þ/þ or Adamts5 À/À mice did not reveal differences in the distribution as percentage of the total injected dose per gram (ID/g) and the mean standardized uptake value (SUV mean) ( Figure 2D ,E). In SC AT, the ID/g and SUV mean were somewhat elevated for Adamts5 À/À mice. As tissue weight was taken into account, the calculated total lesion glycolysis (TLG) was higher for both SC AT and BAT of Adamts5
which is in line with a somewhat enhanced glucose metabolism.
3.2. ADAMTS5 deficiency is associated with enhanced browning of SC AT Next, we examined the potential effect of ADAMTS5 deficiency on browning of WAT. Gene expression analysis of classical browning markers including Ucp1, Cidea, Prdm16, and Pgc1a revealed that, both on SFD and HFD, all markers are expressed at a significantly higher level in SC AT of Adamts5 À/À as compared to Adamts5 þ/þ mice ( Figure 3A ). In contrast, we observed no effect on the expression of the beige markers Tbx1 and Tmem26 between Adamts5 À/À and Adamts5 þ/þ mice ( Figure 3A) . The browning markers were also expressed at a higher level in GON AT of Adamts5 À/À mice, whereas the expression levels in BAT were comparable to wild-type mice ( Figure S3 ). The markedly higher UCP-1 levels in Adamts5 À/À mice were confirmed at protein level for SC AT ( Figure 3B ), but not for GON AT (not shown). This is due to the fact that GON AT is less sensitive to browning. Separate experiments with a prolonged HFD feeding up to 25 weeks confirmed the findings on WAT and BAT mass and Ucp1 expression in WAT ( Figure S4 ). In addition, to exclude an effect of diet composition on browning of WAT, wild-type and Adamts5 À/À mice were kept on a high-sucrose diet for 4 weeks ( Figure S5 ). In brief, browning of SC AT was not observed in wild-type mice, whereas Adamts5 À/À mice showed markedly enhanced gene expression of Cidea and Ucp1. The latter was further supported by immunoblotting for UCP-1.
To confirm a direct effect of ADAMTS5 on browning of WAT, we derived the stromal-vascular fraction from SC AT of 6e8 week old Adamts5 þ/þ and Adamts5 À/À mice and differentiated these isolated precursor cells towards beige adipocytes. Adipogenic differentiation was demonstrated by Oil Red O staining at day 8 ( Figure 4A,B) . At the end of the differentiation, Adamts5 expression in wild-type cells was significantly reduced as compared to day 0 ( Figure 4C ). Moreover, expression of Ucp1 and Cidea was elevated in cells derived from Adamts5 À/À mice, as compared to wild-type cells ( Figure 4D,E) . Collectively, these data indicate that absence of ADAMTS5 has a direct effect on the differentiation of beige or brown-like cells in the SC AT depot, independent of the diet. 
Activated thermogenic profile in ADAMTS5 deficient mice via adrenergic signaling
To elucidate a potential mechanism for increased browning of the SC AT depot, we probed for the effect of ADAMTS5 deficiency on known pathways that lead to browning. Plasma levels of FGF-21 (Fibroblast Growth Factor 21), a known positive regulator of mitochondrial activity and oxidative capacity, were elevated after HFD feeding but were not significantly different between genotypes ( Figure 5A ). Moreover, several well-described stimulatory pathways (e.g. TGF-b signaling via SMAD2/3 or BMP signaling via SMAD1/5/8) were not affected by ADAMTS5 deficiency (Figure S6A,B) . However, we detected an enhanced PKA activity in Adamts5 À/À mice ( Figure S6C) . One of the phosphorylation targets of PKA is the cAMP responsive elementbinding protein (CREB), which is a transcription factor that can directly drive UCP-1 expression. In SC AT of Adamts5 À/À mice, increased levels of pCREB were detected ( Figure 5B ). In addition, enhanced pCREB levels correspond to elevated UCP-1 levels in Adamts5 À/À mice, whereas gene expression levels of the b 3 -AR were not affected by the genotype ( Figure 5C ). Furthermore, these observations were also confirmed in 8-week old mice ( Figure S6D ). To validate the effects of ADAMTS5 on adrenergic signaling towards UCP-1, we used a cell-based assay with brown preadipocytes containing the UCP1-Luciferase cassette. Cell treatment with the chemical ADAMTS5 inhibitor AGG-523 resulted in significantly increased UCP-1 levels ( Figure 5D ). Interestingly, when AGG-523 treatment was com- Figure S7 ). In the salinegroup, significantly higher Ucp1 and Cidea expression levels in SC and GON AT of Adamts5 À/À mice as compared to Adamts5 þ/þ mice were confirmed; we did not observe this difference after CL treatment ( Figure 6E,F) . Overall, these data support that the effects of ADAMTS5 deficiency on browning of WAT are, at least in part, mediated via activated b 3 -adrenergic signaling.
In a separate experiment, obese Adamts5 þ/þ (48.6 AE 2.0 g) and
Adamts5
À/À (50.4 AE 1.3 g) mice were injected with CL (n ¼ 3 for both). After 4 days, these mice lost 12% and 18% of their initial body weight, respectively. This difference was not due to differences in food intake (3.1 AE 0.9 versus 3.1 AE 1.1 g/day).
3.5. Sub-chronic cold exposure induces weight loss in ADAMTS5 deficient mice Wild-type or ADAMTS5 deficient mice were housed at room temperature (AE24 C; n ¼ 3) or 4 C (n ¼ 6) for 2 weeks. During this period, the food intake did not differ between Adamts5 þ/þ and Adamts5 À/À mice housed at 24 C or at 4 C ( Figure 7A ). All mice gradually gained weight, except for Adamts5 À/À mice kept at 4 C ( Figure 7B ). The BAT mass was higher for Adamts5 À/À as compared to Adamts5 þ/þ mice when housed at either 24 C or at 4 C ( Figure 7C ). In addition, higher expression levels of Ucp1 and Prdm16 were observed in SC AT of Adamts5 À/À mice ( Figure 7D ). Also, UCP-1 protein levels in SC AT of Adamts5 À/À mice were markedly higher as compared to Adamts5 þ/þ mice ( Figure 7E ). In GON AT, no UCP-1 protein was detected. Collectively, these data indicate that ADAMTS5 is involved in the browning of WAT in response to cold exposure and that enhanced stimulation of BAT and browning of WAT are eventually associated with weight loss in the absence of ADAMTS5.
DISCUSSION
Although obesity is a worldwide problem with a largely unmet medical need, many processes in adipocyte biology are not fully understood. It was previously reported that ADAMTS5 is upregulated in WAT of obese mice [11, 13] and plays a role in adipogenesis and WAT development in nutritionally-induced obesity [14] . In the present study, we report a strikingly increased mass of BAT in Adamts5 À/À mice as compared to wild-type mice. As BAT is a regulator of thermogenesis, we monitored body temperature, energy expenditure, and heat production. With indirect calorimetry, we observed a significant increase in thermogenesis in ADAMTS5 deficient mice (monitored over a 24 h period). PET scanning confirmed metabolic activity of the BAT and ex vivo tracer distribution analysis revealed small increases in glucose metabolism of the interscapular BAT depot. However, it should be noted, that FDG measurements are based on glucose uptake, which is only one function of BAT. Recent studies on human BAT raised some questions as to whether it resembles rodent brown or beige cells [22e25]. However, Lidell et al. demonstrated that the interscapular depot of BAT in human infants indeed consists of classical brown adipocytes [26] . Interestingly, there is a positive correlation between detectable BAT and resting metabolic rate, but an inverse correlation with BMI and fat mass [27e29]. However, intense cold acclimation (i.e. daily 6 h at 15e16 C for 10 days) showed that BAT recruitment/activity was comparable between lean and obese individuals [30, 31] . This study also indicated that BAT capacity is not hampered by obesity per se. Non-shivering thermogenesis via maximal BAT stimulation (adults have AE50 g BAT) could increase the basal metabolic rate up to 5%, which would have a substantial impact on weight regulation (up to 4 kg fat loss per year) [32] . Perhaps more interesting was the effect of the absence of ADAMTS5 on browning of WAT. Igniting thermogenesis within WAT has become of major interest over the last decade, as it might be an elegant mechanism to tackle obesity and improve metabolic health. There is now clear evidence for the existence of beige cells in humans [33] . Browning of WAT mostly occurs in inguinal SC AT and is only rarely observed in GON AT [34] . In agreement, we observed elevated gene expression of the browning markers in both SC and GON AT, whereas at the protein level UCP-1 was only detected in SC AT. The question remained whether the observed effects of ADAMTS5 deficiency on WAT browning were a direct effect. We have previously shown that differentiation of 3T3-F442A preadipocytes into mature adipocytes is impaired with stable Adamts5 gene silencing, and that de novo adipogenesis (fat formation) in Nude mice following injection of 3T3-F442A cells with Adamts5 knockdown was significantly reduced, as compared to control cells [14] . This is compatible with the observed reduction in SC and GON AT mass in Adamts5 À/À mice on HFD. Adipose tissue specific knockout or overexpression of ADAMTS5 could further support specificity of the phenotype. Since brown/beige/white adipocytes derive from different progenitors, the 3T3-F442A preadipocytes, which are committed to the adipocyte lineage, might not be the best model to study the effects of ADAMTS5 on "browning". Therefore, we derived progenitor cells from the SVF of the SC AT depot of both wild-type and Adamts5 À/À mice and stimulated their differentiation towards beige cells. Cells without ADAMTS5 showed an increased beige differentiation capacity, albeit less pronounced than in the in vivo setting, thus supporting the direct effect of ADAMTS5 on browning. Interestingly, it was reported that paucity of brown adipose tissue may trigger a compensatory mechanism leading to the recruitment of beige/brown-like adipocytes [35] . However, in our mouse model there was no paucity of BAT or reduced BAT activity, suggesting that the observed effects on browning are not the consequence of a compensatory mechanism. Furthermore, using brown preadipocytes with the luciferase reporter coupled to the UCP1 promotor, we showed that ADAMTS5 inhibition is associated with enhanced UCP1 expression. There are two well-known mechanisms to activate BAT and induce browning of WAT, i.e. stimulation of b 3 -AR signaling or exposure to cold. Treatment of wild-type mice with the b 3 -AR agonist CL-316,243 resulted in browning of WAT and reduced SC and GON AT mass. These relatively small effects did not result in an overall significant effect on total body weight. In contrast, treatment of Adamts5 À/À mice with CL-316,243 did not result in reduced WAT mass nor a further increase in browning. Alternatively, exposing mice to cold resulted in enhanced BAT mass and more pronounced browning of WAT in Adamts5 À/À mice. After acclimatization and an initial drop in body weight, wild-type mice regained body weight. In contrast, Adamts5 À/À mice gradually lost body weight, indicating that the full activation of BAT and increased browning of WAT is eventually associated with weight loss. Intriguingly, under normal conditions, we observed a constitutive phosphorylation of CREB at Ser-133 in Adamts5 À/À mice. This is associated with elevated PKA activity, indicating that these effects are mediated through constitutive signaling of the b 3 -adrenergic pathway.
The regulation of this pathway in our mouse model remains elusive, but ADAMTS5 activity appears to be required for signaling to browning via the b 3 -AR-PKA-CREB-UCP1 axis. Recently, it has been shown that during diet-induced thermogenesis increased UCP-1 results from abrogated PP2A-mediated CREB dephosphorylation independent of b 3 -adrenergic signaling [36] . Thus, other mechanisms may contribute to elevated pCREB levels. It is believed that the beige cells are bifunctional, as they store fat in absence of thermogenic stimulation or alternatively, produce heat when the appropriate signals reach the cells [25] . Reversible transdifferentiation/interconversion of pre-existing white adipocytes into beige cells is assumed to be responsible for this phenomenon [37, 38] . However, Wang et al. showed with a pulse-chase fate-mapping technique that the majority, if not all, of beige adipocytes arise from a distinct precursor population rather than from white adipocytes [39] . Nonetheless, these two independent processes might simply coexist. ADAMTS5-mediated remodeling of the ECM to allow transdifferentiation/recruitment could be a possible mechanism. It is indeed known in tumorigenesis that remodeling of the microenvironment plays a role in epithelial-to-mesenchymal transition [40] . However, for browning, the involved ECM components, if any, remain to be identified. Although ADAMTS5 (aggrecanase-2) is the most prominent enzyme in aggrecan degradation, it also degrades other substrates including versican, neurocan, brevican, decorin, biglycan, collagen, and, only weakly, fibronectin, and gelatin [41e43]. Although ADAMTS5 has been primarily studied in osteoarthritis [44] , other studies have revealed emerging roles for ADAMTS5 during development and disease [45] . ADAMTS5 is indeed expressed in several tissues, including kidney, lung, heart, central and peripheral nervous system, skeletal muscle, and liver [45, 46] . To our knowledge, ours is the first report that metalloproteinases are involved in the transition between white-beige cells. It has been reported previously that a subpopulation of mice with a deletion of the catalytic site of ADAM17/ TACE (TNFa converting enzyme), that survive to adulthood, have a hypermetabolic phenotype associated with increased UCP-1 levels in BAT [47] . One of the major healthcare challenges for modern society will be to maintain or achieve metabolic health. In this respect, we have previously reported that ADAMTS5 deficiency is accompanied by protection against fatty liver disease and by an enhanced insulin sensitivity [46] . Whereas glucose levels were comparable for both genotypes, plasma insulin levels were significantly lower for Adamts5 À/À mice as compared to Adamts5 þ/þ mice on HFD. Insulin tolerance tests confirmed better insulin sensitivity on HFD, and there was no difference in plasma adiponectin levels, but leptin levels were significantly lower for Adamts5 À/À mice [46] . We cannot exclude that these findings are directly associated to the enhanced browning of WAT and increased BAT mass. Indeed, Adamts5 À/À mice are protected from hepatic mitochondrial dysfunction as indicated by increased mitochondrial respiratory chain complex activity, higher ATP levels and higher expression of antioxidant enzymes [46] . Furthermore, adipocyte-selective ablation of PRDM16 causes impaired beige adipose conversion, accompanied by metabolic dysfunction, as these mice develop severe insulin resistance and hepatic steatosis when kept on HFD [48] . In general, stimulating thermogenesis in brown and/ or beige adipocytes, thereby utilizing large amounts of stored energy (fatty acids and glucose), seems an attractive strategy to increase energy expenditure and thus to treat obesity and diabetes [5, 33, 49, 50] . We confirmed that after a Western-type diet, the weights of gonadal and subcutaneous adipose tissue depots were significantly lower for Adamts5 À/À mice compared to wild-type mice [14] . Hence, the identification of ADAMTS5 as a negative regulator of BAT mass and browning of WAT is potentially very promising for the development of new therapeutic strategies. Unfortunately, no information is available at present on ADAMTS5 levels in obese humans and, to our knowledge, ADAMTS5 deficiency in man has not been reported. As ADAMTS5 deficient mice have no obvious phenotype, are viable, fertile, and show no histologically detectable differences from wild-type littermates, neutralization of ADAMTS5 in vivo may be a viable therapeutic strategy. However, therapeutic modulation of ADAMTS5 may not yield the same effects as observed in this specific genetic mouse model with total ADAMTS5 deficiency.
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